6505--Abiraterone Acetate Tablets

Cancelled Solicitation Posted

Solicitation number
36E79724R0023
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs (VA) National Acquisition Center is issuing a solicitation for a national contract to procure Abiraterone Acetate tablets. The contract will establish a supply source for these drugs, which will be distributed through the VA and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) programs. Offerors must provide pricing for all line items for the base year and four one-year option years. The awarded contract will have an implementation period of up to 60 days, followed by a one-year ordering period. The Government may exercise four one-year option periods. Offers are due by October 2, 2024 at 2:30 PM CT. Pricing must include a 0.5% Cost Recovery Fee, and small business subcontracting plan requirements apply for large businesses.

There is no set-aside designation for this opportunity. The total annual estimated usage for VA, Federal Health Care Center (FHCC), State Veteran Homes (SVH) - Option 2, DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP) is provided. The Government participants authorized to use the contract are listed. The place of performance for this contract is not specified.

Notice text

N/A

Files

File Type Posted
36E79724R0023.docx DOCX document

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
6505--Abiraterone Acetate Tablets Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity